GOOG

396.87

+0.03%↑

GOOG.US

393.1

-0.08%↓

META.US

611.37

-0.52%↓

NFLX

89.71

+3.01%↑

TMUS

190.53

+2.88%↑

GOOG

396.87

+0.03%↑

GOOG.US

393.1

-0.08%↓

META.US

611.37

-0.52%↓

NFLX

89.71

+3.01%↑

TMUS

190.53

+2.88%↑

GOOG

396.87

+0.03%↑

GOOG.US

393.1

-0.08%↓

META.US

611.37

-0.52%↓

NFLX

89.71

+3.01%↑

TMUS

190.53

+2.88%↑

GOOG

396.87

+0.03%↑

GOOG.US

393.1

-0.08%↓

META.US

611.37

-0.52%↓

NFLX

89.71

+3.01%↑

TMUS

190.53

+2.88%↑

GOOG

396.87

+0.03%↑

GOOG.US

393.1

-0.08%↓

META.US

611.37

-0.52%↓

NFLX

89.71

+3.01%↑

TMUS

190.53

+2.88%↑

Начало・Списък с акции・Solventum Corp

Solventum Corp

Затворен

76.16 2.49

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

73.98

Максимум

76.4

Ключови измерители
By Trading Economics
Приходи	-50M 13M
Продажби	9M 2B
P/E Средно за сектора	9.072 76.909
EPS	1.48
Марж на печалбата	0.648
Служители	20,584
EBITDA	-273M 216M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+11.37% upside

Дивиденти
By Dow Jones
Следващи печалби	6.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	1.1B 13B
Предишно отваряне	73.67
Предишно затваряне	76.16

Solventum Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

25.06.2025 г., 21:19 ч. UTC

Придобивния, сливания и поглъщания

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

27.02.2026 г., 21:30 ч. UTC

Печалби

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27.02.2026 г., 15:07 ч. UTC

Печалби

Solventum Beat Wall Street Earnings Estimates. The Stock Is Down. -- Barrons.com

27.02.2026 г., 13:12 ч. UTC

Печалби

Solventum Beat Wall Street Earnings Estimates. The Stock Is Down. -- Barrons.com

2.09.2025 г., 12:15 ч. UTC

Придобивния, сливания и поглъщания

Thermo Fisher Scientific Completes Acquisition Of Sanofi's Ridgefield, New Jersey Site >TMO

2.09.2025 г., 12:08 ч. UTC

Придобивния, сливания и поглъщания

Solventum Had Seen 2025 Adjusted EPS $5.80-$5.95 >SOLV

2.09.2025 г., 12:08 ч. UTC

Придобивния, сливания и поглъщания

Solventum Raises 2025 View To Adj EPS $5.88-Adj EPS $6.03 >SOLV

2.09.2025 г., 12:04 ч. UTC

Придобивния, сливания и поглъщания

Solventum to Use Net Proceeds Primarily to Pay Down Debt >SOLV

2.09.2025 г., 12:03 ч. UTC

Придобивния, сливания и поглъщания

Solventum Closes Sale of Unit to Thermo Fisher for $4 Billion in Cash >SOLV

2.09.2025 г., 12:03 ч. UTC

Придобивния, сливания и поглъщания

Thermo Fisher Completes Acquisition of Purification & Filtration Business of Solventum for About $4B in Cash >TMO

2.09.2025 г., 12:00 ч. UTC

Придобивния, сливания и поглъщания

Solventum Completes Sale of Purification & Filtration Business to Thermo Fisher Scientific >SOLV TMO

Сравнение с други в отрасъла

Ценова промяна

Solventum Corp Прогноза

Ценова цел

By TipRanks

11.37% нагоре

12-месечна прогноза

Среден 82.7 USD 11.37%

Висок 103 USD

Нисък 60 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Solventum Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

12 ratings

Купи

Задържане

Продай

Според 12 анализатори, дали борсови рейтинги на Solventum Corp през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Solventum Corp

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.